FMT is currently used as a treatment for Clostridium difficile infection. The FDA’s regulatory actions are intended to protect patients from unnecessary risk.
Many have criticized the FDA for enacting strict regulations of a treatment that, as of yet, has shown little negative consequence.
More Articles on Gastroenterology:
3 Benefits of Outsourcing Colonoscopy Prep
UHC Recruits Dr. Adam Hansen, Gastroenterology Specialists
AbbVie, Galapagos Partner to Test Possible Chrohn’s Disease Drug
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
